• Overview
  • News
  • Analysis
  • Recos
  • Financials
  • Technicals
  • Peers
  • Shareholdings
  • MF
  • Corp Actions
  • About

Insights

  • Company has no debt since last 5 years. (Source: Standalone Financials)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 6.3% towards employee cost in the year ending Mar 31, 2021. (Source: Standalone Financials)

InsightsWelcure Drugs & Pharmaceuticals Ltd.

  • Zero Debt Burden

    Company has no debt since last 5 years. (Source: Standalone Financials)

  • Employee & Interest Expense

    Company has spent less than 1% of its operating revenues towards interest expenses and 6.3% towards employee cost in the year ending Mar 31, 2021. (Source: Standalone Financials)

Do you find these insights useful?

  • hate it

  • meh

  • love it

Key Metrics

  • 241.52
  • 0.02
  • 6.13
  • 154
  • -7.12
  • 0.00
  • 10.00
  • 0.00
  • -

Returns

  • 1 Day-4.82%
  • 1 Week-22.26%
  • 1 Month-42.24%
  • 3 Months100.8%
  • 1 Year146.08%
  • 3 YearsN.A.
  • 5 Years109.21%

Welcure Drugs Stock Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

NO RATING (NR)

NEGATIVE (1-3)

NEUTRAL (4-7)

POSITIVE (8-10)

In-depth Reports on 4000+ Indian Stocks worth ₹1,499 with ET Prime membership

START FREE TRIAL

Recommendations

Financials

  • Income (P&L)

  • Balance Sheet

  • Cash Flow

  • Ratios

  • Insights

    • Employee & Interest Expense

      Company has spent less than 1% of its operating revenues towards interest expenses and 6.3% towards employee cost in the year ending Mar 31, 2021. (Source: Standalone Financials)
    Quarterly | AnnualJun 2021Mar 2021Dec 2020Sep 2020Jun 2020
    Total Income0.020.050.000.030.05
    Total Income Growth (%)-56.40--100.00-39.41395.15
    Total Expenses0.050.010.000.020.05
    Total Expenses Growth (%)294.07202.56-77.59-61.59168.05
    EBIT-0.020.040.000.010.01
    EBIT Growth (%)-160.30--128.89136.84-
    Profit after Tax (PAT)-0.020.040.000.010.01
    PAT Growth (%)-160.30--128.89136.84-
    EBIT Margin (%)-106.6777.13-43.6911.18
    Net Profit Margin (%)-106.6777.13-43.6911.18
    Basic EPS (₹)-0.020.030.000.010.05
    Annual FY 2010 FY 2008 FY 2007
    Total Revenue1.0226.7525.80
    Total Revenue Growth (%)-96.183.6653.11
    Total Expenses2.8028.6426.58
    Total Expenses Growth (%)-90.237.7442.08
    Profit after Tax (PAT)-1.78-1.93-0.87
    PAT Growth (%)---
    Operating Profit Margin (%)-246.64-5.30-2.17
    Net Profit Margin (%)-432.16-7.52-3.53
    Basic EPS (₹)-1.46-1.59-0.72
    Quarterly | Annual FY 2021 FY 2020 FY 2019 FY 2018 FY 2017
    Total Revenue0.130.080.080.050.09
    Total Revenue Growth (%)61.132.1058.49-42.85-41.43
    Total Expenses0.080.090.080.070.06
    Total Expenses Growth (%)-15.0419.439.6013.66-8.15
    Profit after Tax (PAT)0.06-0.010.00-0.020.03
    PAT Growth (%)--343.20--170.01-67.74
    Operating Profit Margin (%)41.33-11.434.87-38.6030.77
    Net Profit Margin (%)41.33-11.434.87-38.6030.77
    Basic EPS (₹)0.05-0.010.00-0.020.02

    All figures in Rs Cr, unless mentioned otherwise

    No reported Profit & Loss Statement are available.

  • Insights

    • Zero Debt Burden

      Company has no debt since last 5 years. (Source: Standalone Financials)
    Annual FY 2010 FY 2008 FY 2007
    Total Assets6.9017.3519.48
    Total Assets Growth (%)-60.26-10.957.31
    Total Liabilities7.8110.5310.74
    Total Liabilities Growth (%)-25.86-1.9225.77
    Total Equity-0.916.828.75
    Total Equity Growth (%)-113.36-22.03-9.07
    Current Ratio (x)0.491.421.68
    Total Debt to Equity (x)-2.970.410.43
    Contingent Liabilities---
    Annual FY 2021 FY 2020 FY 2019 FY 2018 FY 2017
    Total Assets0.070.020.030.020.04
    Total Assets Growth (%)250.00-33.3350.00-50.00100.00
    Total Liabilities0.000.010.010.000.00
    Total Liabilities Growth (%)-100.000.00---
    Total Equity0.070.010.020.020.04
    Total Equity Growth (%)600.00-50.000.00-50.00300.00
    Current Ratio (x)20.282.384.886.6911.83
    Total Debt to Equity (x)0.000.000.000.000.00
    Contingent Liabilities0.330.33-0.330.27

    All figures in Rs Cr, unless mentioned otherwise

  • Annual FY 2010 FY 2008 FY 2007
    Net Cash flow from Operating Activities0.971.300.39
    Net Cash used in Investing Activities0.190.08-0.14
    Net Cash flow from Financing Activities-1.23-1.43-0.28
    Net Cash Flow-0.07-0.06-0.03
    Closing Cash & Cash Equivalent0.180.100.16
    Closing Cash & Cash Equivalent Growth (%)82.44-36.01-16.48
    Total Debt/ CFO (x)2.812.149.48
    Annual FY 2021 FY 2020 FY 2019 FY 2018 FY 2017
    Net Cash flow from Operating Activities0.04-0.010.00-0.010.02
    Net Cash used in Investing Activities---0.000.00
    Net Cash flow from Financing Activities---0.000.00
    Net Cash Flow0.04-0.010.00-0.010.02
    Closing Cash & Cash Equivalent0.050.010.010.010.02
    Closing Cash & Cash Equivalent Growth (%)801.07-64.8017.92-46.09345.28
    Total Debt/ CFO (x)0.000.000.000.000.00

    All figures in Rs Cr, unless mentioned otherwise

  • Insights

    • ROE Outperforming 5 Year Average

      Company delivered ROE of 79.39% in year ending Mar 31, 2021 outperforming its 5 year avg. of 34.73%. (Source: Standalone Financials)
    Annual FY 2010 FY 2008 FY 2007
    Return on Equity (%)0.00-28.32-9.97
    Return on Capital Employed (%)-56.37-14.21-4.29
    Return on Assets (%)-25.74-11.13-4.48
    Interest Coverage Ratio (x)-1.33-2.57-2.19
    Asset Turnover Ratio (x)5.95147.93126.60
    Price to Earnings (x)-2.25-2.89-6.36
    Price to Book (x)-4.390.820.63
    EV/EBITDA (x)-10.71-8.85-85.39
    EBITDA Margin (%)-148.31-3.62-0.43
    Annual FY 2021 FY 2020 FY 2019 FY 2018 FY 2017
    Return on Equity (%)79.39-66.0616.35-96.9870.38
    Return on Capital Employed (%)79.39-66.0616.35-96.9870.38
    Return on Assets (%)75.47-38.3413.00-82.4764.43
    Interest Coverage Ratio (x)0.000.000.000.000.00
    Asset Turnover Ratio (x)182.60335.44266.56213.67209.40
    Price to Earnings (x)41.84-57.14178.57-94.34185.19
    Price to Book (x)32.9836.3627.8988.13125.31
    EV/EBITDA (x)40.49-50.84161.76-87.88175.42
    EBITDA Margin (%)41.33-11.434.87-38.6030.77

Financial InsightsWelcure Drugs

  • Income (P&L)
  • Balance Sheet
  • Ratios
    • Employee & Interest Expense

      Company has spent less than 1% of its operating revenues towards interest expenses and 6.3% towards employee cost in the year ending Mar 31, 2021. (Source: Standalone Financials)

    • Zero Debt Burden

      Company has no debt since last 5 years. (Source: Standalone Financials)

    • ROE Outperforming 5 Year Average

      Company delivered ROE of 79.39% in year ending Mar 31, 2021 outperforming its 5 year avg. of 34.73%. (Source: Standalone Financials)

Do you find these insights useful?

  • hate it

  • meh

  • love it

Technicals

  • Buy / Sell Signals

  • Price Analysis

  • Pivot Levels & ATR

  • Chart

  • Stock doesnt have any Buy/Sell Signals.

  • Price Analysis Data details are not available.

  • Pivot Levels

    R1R2R3PIVOTS1S2S3
    Classic-------

    Average True Range

    5 DAYS14 DAYS28 DAYS
    ATR---

Peer Comparison

  • Stock Performance

  • Ratio Performance

    • CHART
    • TABLE
    • 1D
    • 1W
    • 1M
    • 3M
    • 6M
    • 1Y
    • 5Y
  • Ratio Performance

    NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
    Welcure Drugs241.52-6.780.00-56.37-25.7437.20-246.64-432.16-1.460.49-2.972.81
    Norris Medicine-1.95-3.770.00-22.36-13.82-27.02-35.68-36.22-2.840.93-6.07-5.20
    VeerhealthCare22.060.592.315.071.7665.787.132.710.464.130.18-6.96
    Colinz Labs33.051.151.903.371.480.043.191.71-0.013.630.060.66
    Beryl Drugs8.670.880.624.650.285.153.730.370.091.130.6225.46
    Add More

    Annual Ratios (%)

    Choose from Peers

    • Nutraplus India
    • Brawn Biotech
    • Unjha Form
    • Bacil Pharma
    • Chemo Pharma

    See All Parameters

Peers InsightsWelcure Drugs & Pharmaceuticals Ltd.

Do you find these insights useful?

  • hate it

  • meh

  • love it

Shareholding Pattern

  • QOQ Change

  • Total Shareholdings

  • Showing Shareholding as on 31 Mar 2021

    Category31 Mar 202131 Dec 202030 Sep 202030 Jun 2020
    Promoters14.1214.1214.1214.12
    Pledge0.000.000.000.00
    FII0.000.000.000.00
    DII0.010.010.010.01
    Mutual Funds0.000.000.000.00
    Others85.8785.8785.8785.87
  • Showing Shareholding as on 31 Mar 2021

    CategoryNo. of SharesPercentage% Change QoQ
    Promoters19,08,40014.12 %0.00
    Pledge00.00 %0.00
    DII2,0000.01 %0.00
    Others1,16,01,70085.87 %0.00

MF Ownership

MF Ownership details are not available.

Top Searches:

Corporate Actions

  • Board Meeting/AGM

  • Dividends

  • Others
  • Meeting DateAnnounced onPurposeDetails
    Jul 12, 2021Jul 05, 2021Board MeetingQuarterly Results
    Jul 12, 2021May 26, 2021AGMBook closure from Jul 6, 2021 to Jul 12, 2021
    Apr 26, 2021Apr 19, 2021Board MeetingAudited Results
    Jan 16, 2021Jan 06, 2021Board MeetingQuarterly Results
    Oct 16, 2020Oct 08, 2020Board MeetingQuarterly Results
  • Dividend announcements are not available.

  • All TypesEx-DateRecord DateAnnounced onDetails
    RightsJan 01, 1996Jan 25, 1996Oct 09, 1996Rights ratio: 1 share for every 1 held at a price of Rs 10.0

About Welcure Drugs

Welcure Drugs & Pharmaceuticals Ltd., incorporated in the year 1996, is a Small Cap company (having a market cap of Rs 6.13 Crore) operating in Pharmaceuticals sector. Welcure Drugs & Pharmaceuticals Ltd. key Products/Revenue Segments include Commission for the year ending 31-Mar-2021. Show More

  • Executives

  • Auditors

  • SC

    Sudhir Chandra

    Managing Director

    DC

    Dharam Chand Jain

    Non Executive Director

    MB

    Mitashi Bisaria

    Non Executive Director

    GJ

    Gagan Juneja

    Independent Director

    Show More

Address

B-9 & 10, Laxmi Towers,LSC, C Block,New Delhi, Delhi - 110034

More Details

Welcure Drugs Share Price Update

Welcure Drugs & Pharmaceuticals Ltd. share price moved down by -4.82% from its previous close of Rs 4.77. Welcure Drugs & Pharmaceuticals Ltd. stock last traded price is 4.54

Share PriceValue
Today/Current/Last4.54
Previous Day4.77

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

Tell us about you

Find us at the office

Eastmond- Sukel street no. 62, 79540 Hanga Roa, Easter Island

Give us a ring

Jaquelinee Wrate
+74 201 709 645
Mon - Fri, 9:00-15:00

Reach out